CHRS 240816 1.00C (CHRS240816C1000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CHRS240816C1000

Watchlist

0.49
+0.19+63.33%

15min DelayClose Aug 9 16:00 ET

0.49High0.49Low

Intraday

5D
Daily

News

Coherus BioSciences, Inc. (NASDAQ:CHRS) Just Reported, And Analysts Assigned A US$7.67 Price Target
Simply Wall StAug 11 08:52 ET
Coherus BioSciences Second Quarter 2024 Earnings: Beats Expectations
Yahoo FinanceAug 10 08:47 ET
Strong Financial Performance and Market Share Growth Underpin Buy Rating for Coherus Biosciences
TipRanksAug 9 09:59 ET · Ratings
Buy Rating Justified by Coherus Biosciences' Strong Udenyca Sales and Promising Pipeline
TipRanksAug 9 07:19 ET · Ratings
Express News | Coherus BioSciences Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
BenzingaAug 8 17:19 ET
Express News | Coherus BioSciences Sees FY24 R&D And SG&A Expenses $250M-$265M
BenzingaAug 8 17:10 ET

Comments

Abela

Aug 8 16:26

$Coherus BioSciences (CHRS.US)$ 👀👀👀

Ducati999

Aug 2 08:52

Double bottom

$Coherus BioSciences (CHRS.US)$ $Coherus BioSciences (CHRS.US)$
D chart shows double bottom. Time to load up.

Ducati999

Aug 1 09:02

Quarter result

$Coherus BioSciences (CHRS.US)$ what do you all think of the quarter results?

Ducati999

Jul 2 12:39

Good News

$Coherus BioSciences (CHRS.US)$ Loaded up more. Goods news that company has means to raise funds and not through shares issuance!

Trytosaveabit

Jul 2 07:42

Update

$Coherus BioSciences (CHRS.US)$ Reuters· 6 mins ago
Coherus BioSciences Inc - Apotex Agreed to Pay to Company an Upfront Payment of $6.25 Mln United States Dollars under license agreement